Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Seth A Rosenthal, Chen Hu, Oliver Sartor, Leonard G Gomella, Mahul B Amin, James Purdy, Jeff M Michalski, Mark G Garzotto, Nadeem Pervez, Alexander G Balogh, George B Rodrigues, Luis Souhami, M Neil Reaume, Scott G Williams, Raquibul Hannan, Eric M Horwitz, Adam Raben, Christopher A Peters, Felix Y Feng, William U Shipley Show all
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2019
Awarded by National Cancer Institute
Awarded by NATIONAL CANCER INSTITUTE
Supported by Grants No. U10CA21661 (Radiation Therapy Oncology Group Operations and Statistics & Data Management Center), U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology Statistical and Data Management Center), and U24CA180803 (Imaging and Radiation Oncology Core) from the National Cancer Institute and by Sanofi.